Search research articles
Contact Us
Filters
Showing results (131-140 of 297) with videos related to
Page
of 30
Sort By:
Acta Neuropathologica Communications
|
December 14, 2020
Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development
Dominik Röhr, Baayla D C Boon, Martin Schuler, et al.
BMC Cancer
|
May 7, 2015
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
Christoph Pöttgen, Martin Stuschke, Britta Graupner, et al.
Cancer Medicine
|
February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting
Levon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
Daniel C Christoph, Andreas-Claudius Hoffmann, Thomas C Gauler, et al.
Future Oncology (London, England)
|
January 30, 2018
Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies
Federico Cappuzzo, Ross Soo, Maximilian Hochmair, et al.
Journal of Cancer Research and Clinical Oncology
|
September 7, 2022
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
Vivian Rosery, Stephan Mika, Kurt Werner Schmid, et al.
Applied Psychophysiology and Biofeedback
|
November 19, 2022
Cancer Patients' Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control Study
Kira Schmidt, Marvin Krawutschke, Axel Kowalski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
Paul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2020
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve
Nika Guberina, Christoph Pöttgen, Martin Schuler, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2020
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
Timm M Reissig, Linda Sara, Saskia Ting, et al.
Page
of 30
Search research articles
Search
Showing results (131-140 of 297) with videos related to
Sort By:
Page
of 30
Acta Neuropathologica Communications
|
December 14, 2020
Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development
Dominik Röhr, Baayla D C Boon, Martin Schuler, et al.
BMC Cancer
|
May 7, 2015
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
Christoph Pöttgen, Martin Stuschke, Britta Graupner, et al.
Cancer Medicine
|
February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting
Levon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
Daniel C Christoph, Andreas-Claudius Hoffmann, Thomas C Gauler, et al.
Future Oncology (London, England)
|
January 30, 2018
Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies
Federico Cappuzzo, Ross Soo, Maximilian Hochmair, et al.
Journal of Cancer Research and Clinical Oncology
|
September 7, 2022
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
Vivian Rosery, Stephan Mika, Kurt Werner Schmid, et al.
Applied Psychophysiology and Biofeedback
|
November 19, 2022
Cancer Patients' Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control Study
Kira Schmidt, Marvin Krawutschke, Axel Kowalski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2020
HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
Paul Stockhammer, Cassandra Su Lyn Ho, Luca Hegedus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2020
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve
Nika Guberina, Christoph Pöttgen, Martin Schuler, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 18, 2020
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
Timm M Reissig, Linda Sara, Saskia Ting, et al.
Page
of 30